Systemic inflammation evoked by cardiopulmonary bypass (CPB) leads to acute lung injury (ALI) and respiratory failure. Although recombinant human soluble thrombomodulin (rTM) consists of three domains (D1–3), is reported to attenuate systemic inflammation through the N-terminal lectin-like domain (D1), anticoagulant domain (D2) may exacerbate coagulopathy after CPB. We investigated the potential of selective D1 against CPB-mediated ALI free from anticoagulant effects using a rat CPB model.
Rats were divided into three groups: control (CPB alone, n = 5), D1 (CPB + D1, n = 4), and D123 (CPB + D123, n = 6). D1 or D123 was administrated to the rats of each group before CPB establishment. Blood samples are collected before, during and after CPB. Blood coagulability was assessed by a coagulation analyzer. Lung samples are collected at 1 h after the termination of CPB for histological analyses.
D123 group exhibited significantly prolonged glass beads-activated clotting time with heparinase after CPB compared to that in control group, whereas no significant prolongation in control and D1 group (control vs. D1 vs. D123: 65.4 ± 9.2 vs. 65.3 ± 10.9 vs. 83.5 ± 4.6 s, p = 0.036 [control vs. D123], 0.99 [control vs. D1]) indicating the absence of anticoagulant activities of D1. Histological studies revealed less congestion, edema, inflammation, and hemorrhage in both D1 and D123 groups compared to those in control group indicating protective effects of both D1 and D123 against ALI mediated by CPB.
N-terminal lectin-like domain of rTM may reduce the risk of ALI without anticoagulant effects.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Boyle EM Jr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 1997;63:277–84.
Apostolakis E, Filos KS, Koletsis E, Dougenis D. Lung dysfunction following cardiopulmonary bypass. J Card Surg. 2010;25:47–55.
Ge J, Tian J, Yang H, Hou L, Wang Z, He Z, et al. Alpha7 nicotine acetylcholine receptor agonist PNU-282987 attenuates acute lung injury in a cardiopulmonary bypass model in rats. Shock. 2017;47:474–9.
Imura H, Caputo M, Lim K, Ochi M, Suleiman MS, Shimizu K, et al. Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg. 2009;137:1530–7.
Isik AF, Kati I, Bayram I, Ozbek H. A new agent for treatment of acute respiratory distress syndrome: thymoquinone An experimental study in a rat model. Eur J Cardiothorac Surg. 2005;28:301–5.
Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest. 2005;115:1267–74.
Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, et al. A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem. 1989;264:4872–6.
Hayakawa M, Yamakawa K, Saito S, Uchino S, Kudo D, Iizuka Y, et al. Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group Recombinant human soluble thrombomodulin and mortality in sepsis induced disseminated intravascular coagulation. A multicenter retrospective study. Thromb Haemost. 2016;115:1157–66.
Hirao S, Minakata K, Masumoto H, Yamazaki K, Ikeda T, Minatoya K, et al. Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model. J Thorac Cardiovasc Surg. 2017;154:1973–83.
Davidson S. State of the art—how I manage coagulopathy in cardiac surgery patients. Br J Haematol. 2014;164:779–89.
Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost. 1985;11:281–92.
Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med. 2004;30:1873–81.
Taki T, Masumoto H, Funamoto M, Minakata K, Yamazaki K, Ikeda T, et al. Fetal mesenchymal stem cells ameliorate acute lung injury in a rat cardiopulmonary bypass model. J Thorac Cardiovasc Surg. 2017;153:726–34.
Funamoto M, Masumoto H, Takaori K, Taki T, Setozaki S, Yamazaki K, et al. Green tea polyphenol prevents diabetic rats from acute kidney injury after cardiopulmonary bypass. Ann Thorac Surg. 2016;101:1507–13.
Hirao S, Masumoto H, Itonaga T, Minatoya K. A recovery cardiopulmonary bypass model without transfusion or inotropic agents in rats. J Vis Exp. 2018. https://doi.org/10.3791/56986.
Hamamoto M, Suga M, Nakatani T, Takahashi Y, Sato Y, Inamori S, et al. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model. Eur J Cardiothorac Surg. 2004;25:833–8.
Hagiwara S, Iwasaka H, Matsumoto S, Hasegawa A, Yasuda N, Noguchi T. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models. Shock. 2010;33:282–8.
Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Adams DH. Predictors and early and late outcomes of respiratory failure in contemporary cardiac surgery. Chest. 2008;133:713–21.
Nakamura H, Yamaguchi H, Amano A, Nakao T. Venovenous extracorporeal membrane oxygenation is effective against post-cardiotomy acute respiratory failure in adults. Gen Thorac Cardiovasc Surg. 2013;61:402–8.
Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685–93.
Mohri M, Gonda Y, Oka M, Aoki Y, Gomi K, Kiyota T, et al. The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis). Blood Coagul Fibrinolysis. 1997;8:274–83.
We thank Asahi Kasei Pharma Co. for providing the recombinant human soluble thrombomodulin. We thank Dr. S. Kawamoto (Kyoto University) for the technical supports in blood coagulation examinations. We thank Mr. S. Miyake and Ms. Y. Matsubara (Kyoto University) for technical supports in histological assessments. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (to K. Y.) [Grant number 16H05424].
Conflict of interest
The authors declare that no conflict of interest exists.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Itonaga, T., Hirao, S., Yamazaki, K. et al. The N-terminal lectin-like domain of thrombomodulin reduces acute lung injury without anticoagulant effects in a rat cardiopulmonary bypass model. Gen Thorac Cardiovasc Surg 68, 785–792 (2020). https://doi.org/10.1007/s11748-020-01292-8
- Cardiopulmonary bypass
- Acute lung injury
- Animal model